1. Home
  2. FCF vs AGIO Comparison

FCF vs AGIO Comparison

Compare FCF & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

HOLD

Current Price

$16.80

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.80

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
AGIO
Founded
1934
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
FCF
AGIO
Price
$16.80
$27.80
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$19.75
$37.63
AVG Volume (30 Days)
785.7K
708.3K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
3.21%
N/A
EPS Growth
5.76
N/A
EPS
1.47
N/A
Revenue
N/A
$43,011,000.00
Revenue This Year
$16.32
$75.68
Revenue Next Year
$6.25
$167.63
P/E Ratio
$11.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.54
$22.24
52 Week High
$19.08
$46.00

Technical Indicators

Market Signals
Indicator
FCF
AGIO
Relative Strength Index (RSI) 33.97 46.37
Support Level $16.26 $26.48
Resistance Level $16.96 $29.49
Average True Range (ATR) 0.42 1.13
MACD -0.14 -0.17
Stochastic Oscillator 21.40 25.09

Price Performance

Historical Comparison
FCF
AGIO

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: